NCT03586583

Brief Summary

The purpose of the feature comparison study is to evaluate general mammographic features in images of the same breast when reconstructed with modified (ISR and DVIIm) processing as compared to the original processing (FBP with EDR and MFP).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
600

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jun 2018

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 30, 2018

Completed
Same day until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2018

Completed
2 days until next milestone

First Submitted

Initial submission to the registry

July 2, 2018

Completed
11 days until next milestone

First Posted

Study publicly available on registry

July 13, 2018

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 19, 2018

Completed
1.5 years until next milestone

Results Posted

Study results publicly available

May 20, 2020

Completed
Last Updated

September 21, 2023

Status Verified

September 1, 2023

Enrollment Period

Same day

First QC Date

July 2, 2018

Results QC Date

April 17, 2020

Last Update Submit

September 15, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Comparison of ISR (Modified Processing) to FBP (Original Processing)

    For each reader, the cases judged as non-inferior with modified processing will be calculated for each feature and each view. Non-inferiority will be defined as a score of equivalence between modified and original or a score indicating the modified image processing is superior. Readers compared several general mammographic features using the following 5-point scale: negative 2 (left image much superior) negative 1 (left image somewhat superior) 0 (left and right images are equivalent) positive 1 (right image somewhat superior) positive 2 (right image much superior)

    1 day reading session

Study Arms (2)

FBP (old processing)

Filtered back projection; old processing.

Device: FBP

ISR (new processing)

Iterative super resolution; new processing.

Device: ISR

Interventions

FBPDEVICE

Old processing

FBP (old processing)
ISRDEVICE

New processing

ISR (new processing)

Eligibility Criteria

Age18 Years+
Sexfemale(Gender-based eligibility)
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

600

You may qualify if:

  • Female subjects participating in FMSU2013-004A protocol with known clinical status

You may not qualify if:

  • Female subjects that did not have known clinical status in FMSU2013-004A

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

International HealthCare, LLC

Norwalk, Connecticut, 06851, United States

Location

MeSH Terms

Conditions

Breast Neoplasms

Condition Hierarchy (Ancestors)

Neoplasms by SiteNeoplasmsBreast DiseasesSkin DiseasesSkin and Connective Tissue Diseases

Results Point of Contact

Title
Randy Vader
Organization
Fujifilm Medical Systems USA, Inc.

Study Officials

  • Susan Crennan

    Fujifilm Medical Systems USA, Inc.

    STUDY DIRECTOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
observational
Observational Model
CASE CROSSOVER
Time Perspective
RETROSPECTIVE
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 2, 2018

First Posted

July 13, 2018

Study Start

June 30, 2018

Primary Completion

June 30, 2018

Study Completion

November 19, 2018

Last Updated

September 21, 2023

Results First Posted

May 20, 2020

Record last verified: 2023-09

Data Sharing

IPD Sharing
Will not share

Locations